III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold-Reference-Cited by-同舟云学术

III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold

Published:2011-12 Issue:23 Volume:21 Page:6982-6986
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Kim Seong Heon,Anilkumar Gopinadhan N.,Zawacki Lisa Guise,Zeng Qingbei,Yang De-Yi,Shao Yuefei,Dong Guizhen,Xu Xiaolian,Yu Wensheng,Jiang Yueheng,Jenh Chung-Her,Hall James W.,Carroll Carolyn DiIanni,Hobbs Doug W.,Baldwin John J.,McGuinness Brian F.,Rosenblum Stuart B.,Kozlowski Joseph A.,Shankar Bandarpalle B.,Shih Neng-Yang

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference13 articles.

1. Chemokine Receptor CXCR3: An Unexpected Enigma

2. Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

3. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

4. Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3

5. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment;Cellular and Molecular Life Sciences;2023-03

2. Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR);Scientific Reports;2017-09-06

3. Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR;MedChemComm;2017

4. Designing small molecule CXCR3 antagonists;Expert Opinion on Drug Discovery;2016-12-30

5. II. Discovery of a novel series of CXCR3 antagonists with a beta amino acid core;Bioorganic & Medicinal Chemistry Letters;2016-11